Exact Mass: 462.2721
Exact Mass Matches: 462.2721
Found 500 metabolites which its exact mass value is equals to given mass value 462.2721
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide
Retinyl beta-glucuronide
Retinyl beta-glucuronide is a natural human metabolite of retinoic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] Retinyl beta-glucuronide is a natural human metabolite of retinoic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate
1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(11Z,14Z-eicosadienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:2(11Z,14Z)/0:0)
LysoPA(20:2(11Z,14Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:2(11Z,14Z)/0:0), in particular, consists of one chain of eicosadienoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Diazepinomicin
Trichomonacid
2beta,9alpha,14alpha-Triacetoxy-3alpha-hydroxy-1(15),8(19)-trinervitadiene
14,15,16-triacetoxy-15,16-epoxy-ent-cleroda-4(18),12E-diene
1alpha-hydroxy-7alpha,14alpha,18-triacetoxy-isopimara-8,15-diene|7alpha,14alpha,18-triacetoxy-8,15-isopimaradien-1alpha-ol
(E)-3,7-dimethyl-1-O-[alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranosyl]-oct-2-en-7-ol
(1S,2R,3S,8S,9S,10S,13S,14S,16S,17R,22R,25R)-21-nor-18beta,27alpha-dimethyl-1beta,2beta,3beta-trihydroxy-25-spirost-4-en-19beta-oic acid
1-[1-(acetyloxy)ethyl]octahydro-6-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-7-(propan-2-yl)-1H-inden-5-yl (2E)-3-methylpent-2-enoate
2-epicaseabalansin C|rel-(2R,4S,5R,8S,9S,10R,18S,19R)-2,18,19-triacetoxycleroda-13(16),14-dien-18,19-oxolane
6alpha,17alpha-dihydroxy-15,17-oxidospongian-16-one 6-butyrate 17 acetate
(3S, 4E, 26E, 28S)-form-3, 28-Dihydroxy-4, 26-triacontadiene-1, 12, 18, 29-tetrahyne-14, 17-dione|(3S,28S)-3,28-dihydroxy-4,27-triacontadiene-1,12,18,29-tetrayne-4,17-dione|adociacetylene D
methyl-4E-9beta-senecioyloxy-14-O-<2-methylbutyryl>-oxyphylloate|methyl-9beta-senecioyloxy-14-O-(2-methylbutyryl)-oxyphylloate|methyl-9beta-senecioyloxy-14-O-<2-methylbutyryl>-oxyphylloate
5,14,19-Tri-Ac-(5R,13(15)E,16Z)-13(15),16-Spatadiene-5,14,18,19-tetrol
14,15,16-Triacetoxy-15,16-epoxy-ent-cleroda-3,12Z-diene
15-O-acetyl-5beta-hydroxyisocharaciol-3-isobutyrate
6,12,13-Tri-Ac-(1alpha,5beta,6beta,9alpha,12xi,13xi)-3,10,14-Prenylguaiatriene-6,9,12,13-tetrol
Thr Lys Ser Lys
Ala Phe Ile Ile
Ala Phe Ile Leu
Ala Phe Leu Ile
Ala Phe Leu Leu
Ala Ile Phe Ile
Ala Ile Phe Leu
Ala Ile Ile Phe
Ala Ile Leu Phe
Ala Leu Phe Ile
Ala Leu Phe Leu
Ala Leu Ile Phe
Ala Leu Leu Phe
Phe Ala Ile Ile
Phe Ala Ile Leu
Phe Ala Leu Ile
Phe Ala Leu Leu
Phe Ile Ala Ile
Phe Ile Ala Leu
Phe Ile Ile Ala
Phe Ile Leu Ala
Phe Leu Ala Ile
Phe Leu Ala Leu
Phe Leu Ile Ala
Phe Leu Leu Ala
Phe Thr Val Pro
Phe Val Pro Thr
Phe Val Thr Pro
Phe Val Val Val
Gly Lys Lys Met
Gly Lys Met Lys
Gly Met Lys Lys
His Ile Pro Pro
His Leu Pro Pro
His Pro Ile Pro
His Pro Leu Pro
His Pro Pro Ile
His Pro Pro Leu
Ile Ala Phe Ile
Ile Ala Phe Leu
Ile Ala Ile Phe
Ile Ala Leu Phe
Ile Ala Pro Tyr
Ile Ala Tyr Pro
Ile Phe Ala Ile
Ile Phe Ala Leu
Ile Phe Ile Ala
Ile Phe Leu Ala
Ile Phe Pro Ser
Ile Phe Ser Pro
Ile His Pro Pro
Ile Ile Ala Phe
Ile Ile Phe Ala
Ile Ile Met Ser
Ile Ile Ser Met
Ile Leu Ala Phe
Ile Leu Phe Ala
Ile Leu Met Ser
Ile Leu Ser Met
Ile Met Ile Ser
Ile Met Leu Ser
Ile Met Ser Ile
Ile Met Ser Leu
Ile Met Thr Val
Ile Met Val Thr
Ile Pro Ala Tyr
Ile Pro Phe Ser
Ile Pro His Pro
Ile Pro Pro His
Ile Pro Ser Phe
Ile Pro Tyr Ala
Ile Ser Phe Pro
Ile Ser Ile Met
Ile Ser Leu Met
Ile Ser Met Ile
Ile Ser Met Leu
Ile Ser Pro Phe
Ile Thr Met Val
Ile Thr Val Met
Ile Val Met Thr
Ile Val Thr Met
Ile Tyr Ala Pro
Ile Tyr Pro Ala
Lys Gly Lys Met
Lys Gly Met Lys
Lys Lys Gly Met
Lys Lys Met Gly
Lys Lys Ser Thr
Lys Lys Thr Ser
Lys Met Gly Lys
Lys Met Lys Gly
Lys Ser Lys Thr
Lys Ser Thr Lys
Lys Thr Lys Ser
Lys Thr Ser Lys
Leu Ala Phe Ile
Leu Ala Phe Leu
Leu Ala Ile Phe
Leu Ala Leu Phe
Leu Ala Pro Tyr
Leu Ala Tyr Pro
Leu Phe Ala Ile
Leu Phe Ala Leu
Leu Phe Ile Ala
Leu Phe Leu Ala
Leu Phe Pro Ser
Leu Phe Ser Pro
Leu His Pro Pro
Leu Ile Ala Phe
Leu Ile Phe Ala
Leu Ile Met Ser
Leu Ile Ser Met
Leu Leu Ala Phe
Leu Leu Phe Ala
Leu Leu Met Ser
Leu Leu Ser Met
Leu Met Ile Ser
Leu Met Leu Ser
Leu Met Ser Ile
Leu Met Ser Leu
Leu Met Thr Val
Leu Met Val Thr
Leu Pro Ala Tyr
Leu Pro Phe Ser
Leu Pro His Pro
Leu Pro Pro His
Leu Pro Ser Phe
Leu Pro Tyr Ala
Leu Ser Phe Pro
Leu Ser Ile Met
Leu Ser Leu Met
Leu Ser Met Ile
Leu Ser Met Leu
Leu Ser Pro Phe
Leu Thr Met Val
Leu Thr Val Met
Leu Val Met Thr
Leu Val Thr Met
Leu Tyr Ala Pro
Leu Tyr Pro Ala
Met Gly Lys Lys
Met Ile Ile Ser
Met Ile Leu Ser
Met Ile Ser Ile
Met Ile Ser Leu
Met Ile Thr Val
Met Ile Val Thr
Met Lys Gly Lys
Met Lys Lys Gly
Met Leu Ile Ser
Met Leu Leu Ser
Met Leu Ser Ile
Met Leu Ser Leu
Met Leu Thr Val
Met Leu Val Thr
Met Ser Ile Ile
Met Ser Ile Leu
Met Ser Leu Ile
Met Ser Leu Leu
Met Thr Ile Val
Met Thr Leu Val
Met Thr Val Ile
Met Thr Val Leu
Met Val Ile Thr
Met Val Leu Thr
Met Val Thr Ile
Met Val Thr Leu
Pro Ala Ile Tyr
Pro Ala Leu Tyr
Pro Ala Tyr Ile
Pro Ala Tyr Leu
Pro Phe Ile Ser
Pro Phe Leu Ser
Pro Phe Ser Ile
Pro Phe Ser Leu
Pro Phe Thr Val
Pro His Ile Pro
Pro His Leu Pro
Pro His Pro Ile
Pro His Pro Leu
Pro Ile His Pro
Pro Ile Pro His
Pro Leu His Pro
Pro Leu Pro His
Pro Pro His Ile
Pro Pro His Leu
Pro Pro Ile His
Pro Pro Leu His
Ser Ile Ile Met
Ser Ile Leu Met
Ser Ile Met Ile
Ser Ile Met Leu
Ser Lys Lys Thr
Ser Lys Thr Lys
Ser Leu Ile Met
Ser Leu Leu Met
Ser Leu Met Ile
Ser Leu Met Leu
Ser Met Ile Ile
Ser Met Ile Leu
Ser Met Leu Ile
Ser Met Leu Leu
Ser Thr Lys Lys
Thr Ile Met Val
Thr Ile Val Met
Thr Lys Lys Ser
Thr Leu Met Val
Thr Leu Val Met
Thr Met Ile Val
Thr Met Leu Val
Thr Met Val Ile
Thr Met Val Leu
Thr Ser Lys Lys
Thr Val Ile Met
Thr Val Leu Met
Thr Val Met Ile
Thr Val Met Leu
Val Phe Val Val
Val Ile Met Thr
Val Ile Thr Met
Val Leu Met Thr
Val Leu Thr Met
Val Met Ile Thr
Val Met Leu Thr
Val Met Thr Ile
Val Met Thr Leu
Val Thr Ile Met
Val Thr Leu Met
Val Thr Met Ile
Val Thr Met Leu
Val Val Phe Val
Val Val Val Phe
2-acetamido-N-[1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide,hydrochloride
Diazepinomicin
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
Fedovapagon
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist
N-[3-[[2-[[4-(dimethylamino)cyclohexyl]amino]-9-propan-2-yl-6-purinyl]amino]phenyl]-2-propenamide
1-(11Z,14Z-Eicosadienoyl)-glycero-3-phosphoric acid
1-[(7,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-[(1-ethyl-2-pyrrolidinyl)methyl]-3-(2-methoxyphenyl)urea
N-(3alpha,12alpha-dihydroxy-7-oxo-5beta-cholan-24-oyl)glycinate
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
(2R)-2-[(4S,5R)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-(1-oxopropylamino)-N-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-(1-oxopropylamino)-N-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
1-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
1-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
1-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
1-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
[(8R,9S,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(1R)-7-methoxy-1-(4-oxanylmethyl)-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide
(2S)-2-[(4R,5S)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-(1-cyclohexenyl)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-14-(1-oxopropylamino)-N-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-14-(1-oxopropylamino)-N-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-14-(1-oxopropylamino)-N-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-14-(1-oxopropylamino)-N-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
1-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
1-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
1-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
1-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
1-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propylurea
(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-14-(1-oxopropylamino)-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
1-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
1-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-3-(1-piperidinyl)propanamide
[(8R,9S,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10S)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10R)-9-[4-[2-(2-fluorophenyl)ethynyl]phenyl]-6-(4-oxanylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(4E,8E)-2-(butanoylamino)-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(propanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-acetamido-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(pentanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
LPEt(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
BisMeLPA(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
methyl 10-hydroxy-2,4a,6a,9,13,14a-hexamethyl-11-oxo-3,4,5,6,14,14b-hexahydro-1h-picene-2-carboxylate
2-[11-(4-hydroperoxy-4-methylpent-2-en-1-yl)-3-methoxy-3,11-dimethyl-2,6-dioxatricyclo[6.4.0.0¹,⁵]dodec-8-en-12-yl]ethenyl 3-methylbut-2-enoate
(4ar,5s,9as)-9a-[(4ar,5s,9ar)-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-9a-yl]-3,4a,5-trimethyl-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-2-one
(1e)-2-[(1s,2s,7s)-2-[(2e)-4-hydroperoxy-4-methylpent-2-en-1-yl]-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
methyl (2s,3ar,4s,5s,5'as,7's,9'ar)-3a-(hydroxymethyl)-1',1',4,5'a,7,7'-hexamethyl-3',6-dioxo-4,4',5,5',7',8',9',9'a-octahydro-3h-spiro[1-benzofuran-2,6'-[2]benzoxepine]-5-carboxylate
methyl 10-hydroxy-2,4a,6,9,12b,14a-hexamethyl-11-oxo-3,4,5,13,14,14b-hexahydro-1h-picene-2-carboxylate
(3s,4e,26e,28s)-3,28-dihydroxytriaconta-4,26-dien-1,12,18,29-tetrayne-14,17-dione
{2-hydroxy-6-[1-hydroxy-3-methyl-5-(1,2,6-trimethylcyclohex-2-en-1-yl)pent-2-en-1-yl]-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl}methyl 3-hydroxybutanoate
(2r,3r,4s,5s,6r)-2-{[(2e)-7-hydroxy-3,7-dimethyloct-2-en-1-yl]oxy}-6-({[(2r,3r,4r,5r)-5-(hydroxymethyl)-3,4-dimethyloxolan-2-yl]oxy}methyl)oxane-3,4,5-triol
2-[2-(4-hydroperoxy-4-methylpent-2-en-1-yl)-5-(methoxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate
(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1s)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-2,6,11,15-tetramethylheptadeca-2,4,6,8,10,12,14,16-octaenoic acid
10-deacetyltaxuyunnanine c
{"Ingredient_id": "HBIN000092","Ingredient_name": "10-deacetyltaxuyunnanine c","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4787","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18-o-methyl-5-epi-vibsanin k
{"Ingredient_id": "HBIN002145","Ingredient_name": "18-o-methyl-5-epi-vibsanin k","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(C(=O)C(=CCC1(C)CC=CC(C)(C)OO)COC)CC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14397","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18-o-methylvibsanin k
{"Ingredient_id": "HBIN002148","Ingredient_name": "18-o-methylvibsanin k","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(C(=O)C(=CCC1(C)CC=CC(C)(C)OO)COC)CC(=O)C)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10695370","DrugBank_id": "NA"}
1-dehydroxybaccatin
{"Ingredient_id": "HBIN002472","Ingredient_name": "1-dehydroxybaccatin","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC1=C2C(CC3(C(CC(C2(C)C)CC1OC(=O)C)C4COC4CC3OC(=O)C)C)OC(=O)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25938","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101225011","DrugBank_id": "NA"}
2alpha-hydroxy-5alpha,10beta,14beta-triacetoxytaxa-4(20),11-diene
{"Ingredient_id": "HBIN005284","Ingredient_name": "2alpha-hydroxy-5alpha,10beta,14beta-triacetoxytaxa-4(20),11-diene","Alias": "2\u03b1-hydroxy-5\u03b1,10\u03b2,14\u03b2-triacetoxytaxa-4(20),11-diene","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC1=C2C(CC3(CCC(C(=C)C3C(C(C2(C)C)C(C1)OC(=O)C)O)OC(=O)C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31281;10778","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-epi-neovibsanin d
{"Ingredient_id": "HBIN013182","Ingredient_name": "7-epi-neovibsanin d","Alias": "NA","Ingredient_formula": "C26H38O7","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(CC=C2C13C(CC(O3)(C)OC)OC2)(C)CC=CC(C)(C)OO)C","Ingredient_weight": "462.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15464","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11385697","DrugBank_id": "NA"}
biatractylolide
{"Ingredient_id": "HBIN018397","Ingredient_name": "biatractylolide","Alias": "Biatractylolide","Ingredient_formula": "C30H38O4","Ingredient_Smile": "CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)C45CC6(CCCC(=C)C6CC4=C(C(=O)O5)C)C)C","Ingredient_weight": "462.6 g/mol","OB_score": "17.44616598","CAS_id": "NA","SymMap_id": "SMIT02742","TCMID_id": "32490","TCMSP_id": "MOL000062","TCM_ID_id": "6226","PubChem_id": "10813930","DrugBank_id": "NA"}
biepiasterolide
{"Ingredient_id": "HBIN018493","Ingredient_name": "biepiasterolide","Alias": "NA","Ingredient_formula": "C30H38O4","Ingredient_Smile": "CC1=C2CC3C(=C)CCCC3(CC2(OC1=O)C45CC6(CCCC(=C)C6CC4=C(C(=O)O5)C)C)C","Ingredient_weight": "462.62","OB_score": "NA","CAS_id": "252027-27-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6212","PubChem_id": "11351701","DrugBank_id": "NA"}